Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lim, Sue, Bast, Darrin, McGeer, Allison, de Azavedo, Joyce, Low, Donald E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Centers for Disease Control and Prevention 2003
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3023429/
https://ncbi.nlm.nih.gov/pubmed/12890324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid0907.020589
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller